Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-06-01 Sale |
2020-06-02 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $603.23 | $60,323 | 28,743 (Direct) |
View |
| 2020-05-28 Sale |
2020-06-01 4:08 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
2,000 | $587.75 | $1,175,510 | 125,265 (Indirect Direct) |
View |
| 2020-05-28 Sale |
2020-06-01 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
1,000 | $578.94 | $578,940 | 6,643 (Direct) |
View |
| 2020-05-29 Sale |
2020-05-29 4:16 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Sanofi 10% Owner |
22,821,451 | $509.85 | $11,635,516,792 | 400,000 (Indirect Direct) |
View |
| 2020-05-21 Sale |
2020-05-22 6:21 pm |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Chairman of the Board |
783 | $577.49 | $452,178 | 1,002,565 (Indirect Direct) |
View |
| 2020-05-21 Sale |
2020-05-22 6:21 pm |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Chairman of the Board |
148,811 | $564.37 | $83,984,786 | 308,532 (Direct) |
View |
| 2020-05-15 Sale |
2020-05-15 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
8,380 | $572 | $4,793,360 | 14,725 (Indirect Direct) |
View |
| 2020-05-12 Sale |
2020-05-13 9:01 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
150,922 | $569.22 | $85,908,042 | 767,847 (Indirect Direct) |
View |
| 2020-05-11 Sale |
2020-05-13 9:00 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
5,850 | $579.27 | $3,388,750 | 131,615 (Indirect Direct) |
View |
| 2020-05-11 Sale |
2020-05-11 4:39 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
5,305 | $569.52 | $3,021,289 | 51,174 (Indirect Direct) |
View |
| 2020-05-07 Sale |
2020-05-08 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr Industrial O |
39,583 | $564.32 | $22,337,306 | 82,312 (Indirect Direct) |
View |
| 2020-05-06 Sale |
2020-05-08 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
15,000 | $563.97 | $8,459,496 | 1,830 (Direct) |
View |
| 2020-05-07 Sale |
2020-05-08 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
5,118 | $566.52 | $2,899,461 | 10,878 (Direct) |
View |
| 2020-05-06 Sale |
2020-05-07 6:22 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
50,124 | $550.88 | $27,612,509 | 31,322 (Direct) |
View |
| 2020-05-07 Sale |
2020-05-07 4:14 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
1,809 | $562 | $1,016,658 | 19,602 (Indirect Direct) |
View |
| 2020-05-06 Sale |
2020-05-06 4:19 pm |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
2,000 | $560 | $1,120,000 | 7,643 (Direct) |
View |
| 2020-05-01 Sale |
2020-05-04 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $520.37 | $52,037 | 28,843 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-01-03 Gift |
2020-05-22 6:21 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Chairman of the Board |
997 | $0 | 1,002,565 (Indirect) |
View |
| 2020-05-20 Exercise |
2020-05-22 6:21 pm |
N/A 2020-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Chairman of the Board |
312,500 | $0 | 1,002,565 (Direct) |
View |
| 2020-05-20 Tax Withholding |
2020-05-22 6:21 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Chairman of the Board |
79,694 | $570.97 | 308,532 (Direct) |
View |
| 2020-05-20 Exercise |
2020-05-22 6:21 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Chairman of the Board |
80,573 | $30.63 | 308,532 (Direct) |
View |
| 2020-05-14 Tax Withholding |
2020-05-15 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
9,931 | $573.18 | 14,725 (Direct) |
View |
| 2020-05-14 Exercise |
2020-05-15 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
18,311 | $59.2 | 14,725 (Direct) |
View |
| 2020-05-14 Exercise |
2020-05-15 4:03 pm |
N/A 2021-09-01 |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
18,311 | $0 | 14,725 (Direct) |
View |
| 2020-05-11 Tax Withholding |
2020-05-13 9:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
161,578 | $571.43 | 767,847 (Direct) |
View |
| 2020-05-11 Exercise |
2020-05-13 9:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
312,500 | $30.63 | 767,847 (Direct) |
View |
| 2020-05-11 Exercise |
2020-05-13 9:01 pm |
N/A 2020-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
312,500 | $0 | 767,847 (Direct) |
View |
| 2020-05-13 Exercise |
2020-05-13 9:00 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
5,000 | $33.42 | 131,615 (Direct) |
View |
| 2020-05-13 Exercise |
2020-05-13 9:00 pm |
N/A 2021-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
5,000 | $0 | 131,615 (Direct) |
View |
| 2020-05-08 Tax Withholding |
2020-05-11 4:39 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
7,195 | $560.67 | 51,174 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-11 4:39 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
12,500 | $52.03 | 51,174 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-11 4:39 pm |
N/A 2021-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
12,500 | $0 | 51,174 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-08 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr Industrial O |
85,579 | $52.03 | 82,312 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-08 4:04 pm |
N/A 2021-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr Industrial O |
85,579 | $0 | 82,312 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-08 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr Industrial O |
45,996 | $555.77 | 82,312 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-08 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
15,000 | $177.82 | 1,830 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-08 4:03 pm |
N/A 2023-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
15,000 | $0 | 1,830 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-08 4:03 pm |
N/A 2026-09-09 |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
5,118 | $0 | 10,878 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-08 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
5,118 | $391.92 | 10,878 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 6:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
7,830 | $376.69 | 31,322 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 6:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
3,784 | $371.4 | 31,322 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 6:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
10,838 | $413.33 | 31,322 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 6:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
4,960 | $380.95 | 31,322 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 6:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
5,000 | $177.82 | 31,322 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 6:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
8,500 | $273.67 | 31,322 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 6:22 pm |
N/A 2023-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
50,124 | $0 | 31,322 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 6:22 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
9,212 | $520.01 | 31,322 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 4:14 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
5,220 | $376.69 | 19,602 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 4:14 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
250 | $273.67 | 19,602 (Direct) |
View |
| 2020-05-06 Exercise |
2020-05-07 4:14 pm |
N/A 2024-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
5,470 | $0 | 19,602 (Direct) |
View |
| 2020-05-06 Tax Withholding |
2020-05-07 4:14 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
3,661 | $555.77 | 19,602 (Direct) |
View |